应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
FBIO Fortress Biotech Inc.
盘前交易 12-26 08:34:24 EST
1.81
+0.07
+4.02%
盘前
1.81
+0.00
0.00%
08:27 EST
最高
1.81
最低
1.72
成交量
20.54万
今开
1.75
昨收
1.74
日振幅
5.02%
总市值
4,996万
流通市值
3,532万
总股本
2,760万
成交额
36.24万
换手率
1.05%
流通股本
1,951万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
BUZZ--美国股票走势-诺和诺德、特斯拉、微策略
路透中文 · 12-16
BUZZ--美国股票走势-诺和诺德、特斯拉、微策略
BUZZ--美国股票走势-NetApp、霍尼韦尔、世邦魏理仕集团
路透中文 · 12-16
BUZZ--美国股票走势-NetApp、霍尼韦尔、世邦魏理仕集团
BUZZ-Checkpoint Therapeutics 公司的皮肤癌药物获得 FDA 批准后股价上涨
路透中文 · 12-16
BUZZ-Checkpoint Therapeutics 公司的皮肤癌药物获得 FDA 批准后股价上涨
Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻
Reuters · 11-13
Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻
Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻
路透中文 · 11-08
Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻
美国食品及药物管理局批准 Journey Medical 用于治疗长期皮肤病的药物
Reuters · 11-04
美国食品及药物管理局批准 Journey Medical 用于治疗长期皮肤病的药物
HC Wainwright & Co.:重申Fortress Biotech(FBIO.US)评级,由买入调整至买入评级, 目标价由24.
智通财经 · 07-20
HC Wainwright & Co.:重申Fortress Biotech(FBIO.US)评级,由买入调整至买入评级, 目标价由24.
公司概况
公司名称:
Fortress Biotech Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。它是一家生物制药公司,专注于收购和推进资产,通过产品收入、股权持有、股息和特许权使用费收入流提高股东的长期价值。
发行价格:
--
{"stockData":{"symbol":"FBIO","market":"US","secType":"STK","nameCN":"Fortress Biotech Inc.","latestPrice":1.81,"timestamp":1735063200000,"preClose":1.74,"halted":0,"volume":205375,"hourTrading":{"tag":"盘前","latestPrice":1.81,"preClose":1.81,"latestTime":"08:27 EST","volume":7120,"amount":12786.719000000001,"timestamp":1735219638791},"delay":0,"floatShares":19512749,"shares":27604934,"eps":-3.390036,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.07,"latestTime":"12-26 08:34:24 EST","open":1.75,"high":1.81,"low":1.7227,"amount":362438.221663,"amplitude":0.050172,"askPrice":1.96,"askSize":100,"bidPrice":1.64,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.390036,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735223400000},"adr":0,"adjPreClose":1.81,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":1.81,"preClose":1.81,"latestTime":"08:27 EST","volume":7120,"amount":12786.719000000001,"timestamp":1735219638791},"postHourTrading":{"tag":"盘后","latestPrice":1.8,"preClose":1.81,"latestTime":"16:53 EST","volume":8041,"amount":14388.999,"timestamp":1735077198325},"volumeRatio":0.7442761510103293,"impliedVol":0.8279,"impliedVolPercentile":0.3386},"requestUrl":"/m/hq/s/FBIO/wiki","defaultTab":"wiki","newsList":[{"id":"2491914926","title":"BUZZ--美国股票走势-诺和诺德、特斯拉、微策略","url":"https://stock-news.laohu8.com/highlight/detail?id=2491914926","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491914926?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:15","pubTimestamp":1734358514,"startTime":"0","endTime":"0","summary":"nL4N3NH0QL ** Checkpoint Therapeutics Inc CKPT.O:BUZZ--该公司的皮肤癌药物获得美国食品和药物管理局批准后股价上涨。nL4N3NH0QI ** NetApp NTAP.O:BUZZ - JPM将其评级上调至 \"增持\",原因是人工智能引领的增长将改善IT预算。nL4N3NH0R7 ** 霍尼韦尔国际HON.O:BUZZ - 公司称考虑分拆航空业务,股价上涨。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4T3NH10L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","CPRI","LU2552382215.SGD","BK4555","LU1145028129.USD","CBRE","MAS","HON","LU1496350171.SGD","VRDN","LU0417517546.SGD","LU0011850046.USD","LU0130102774.USD","IE0034235188.USD","LU0971096721.USD","EWTX","IE00BDCRKT87.USD","LU1084165304.USD","LU1670628061.USD","LU1917777945.USD","NTAP","PLBY","TSYW.SI","LU2237443465.HKD","LU0980610538.SGD","LU0234572021.USD","MSTR","BK4524","CTLT","LU1670627923.USD","LU0211327993.USD","BHVN","F","BK4596","LU0976567544.SGD","BK4533","BK4146","TSLA","LU0053671581.USD","LU0496365809.HKD","NKE","BK4534","CKPT","FBIO","LU1244550221.USD","LU0070302665.USD","LU1894683348.USD"],"gpt_icon":1},{"id":"2491667185","title":"BUZZ--美国股票走势-NetApp、霍尼韦尔、世邦魏理仕集团","url":"https://stock-news.laohu8.com/highlight/detail?id=2491667185","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491667185?lang=zh_cn&edition=full","pubTime":"2024-12-16 20:14","pubTimestamp":1734351295,"startTime":"0","endTime":"0","summary":"nL4N3NH0QL ** Checkpoint Therapeutics CKPT.O:BUZZ--该公司的皮肤癌药物获得美国食品和药物管理局批准后股价上涨。nL4N3NH0R7 ** 霍尼韦尔国际HON.O:BUZZ - 公司称考虑分拆航空业务,股价上涨。nL4N3NH0Q5 ** Edgewise Therapeutics EWTX.O:BUZZ - 因遗传疾病药物达到中期研究目标而上涨 nL4N3NH0SQ ** 世邦魏理仕集团CBRE.N:BUZZ - 在摩根大通将其评级上调至 \"增持 \"后上涨 nL4N3NH0TA (为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4T3NH0UU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPRI","CBRE","MAS","HON","LU0154245756.USD","IE00B1BXHZ80.USD","LU0316494557.USD","LU0820561909.HKD","LU1244550577.SGD","LU1668664300.SGD","LU1721427968.SGD","LU0234570918.USD","BK4566","NTAP","EWTX","LU1670628061.USD","LU1267930490.SGD","TSYW.SI","BK4207","LU0348723411.USD","LU0980610538.SGD","IE00B3S45H60.SGD","IE00BFXG1179.USD","IE00BK4W5L77.USD","BK4581","LU2023250330.USD","MSTR","LU2413665964.HKD","LU0689472784.USD","CTLT","LU1670627923.USD","BK4574","SG9999002224.SGD","BK4596","SG9999015986.USD","TSLA","LU2413666004.HKD","LU0267386448.USD","LU0823414478.USD","LU1620156130.USD","IE00BZ1G4Q59.USD","BK4079","LU0211326755.USD","IE00BK4W5M84.HKD","CKPT","FBIO","LU1894683348.USD","BK4504"],"gpt_icon":1},{"id":"2491661397","title":"BUZZ-Checkpoint Therapeutics 公司的皮肤癌药物获得 FDA 批准后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2491661397","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491661397?lang=zh_cn&edition=full","pubTime":"2024-12-16 19:25","pubTimestamp":1734348334,"startTime":"0","endTime":"0","summary":"12月16日 - ** 药物开发商Checkpoint Therapeutics CKPT.O的股票在盘前交易中上涨8.9%,达到4美元。** 美国食品和药物管理局周五批准了 公司用于治疗一种皮肤外层癌症的药物。** 公司表示 \"目前正在制定该药物的商业上市计划\"。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241216:nL4S3NH0RI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CKPT","FBIO","BK4139"],"gpt_icon":0},{"id":"2483833862","title":"Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2483833862","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483833862?lang=zh_cn&edition=full","pubTime":"2024-11-13 23:52","pubTimestamp":1731513178,"startTime":"0","endTime":"0","summary":" * Fortress Biotech Inc 将于11月15日公布截至2024年9月30日的业绩报告,预计(),季度收入将出现下降。* LSEG 分析师对 Fortress Biotech Inc 的平均预期是每股亏损 59 美分。* 华尔街对 Fortress Biotech Inc 的 12 个月目标价中位数为 13.00 美元,高于其上一次收盘价 1.70 美元。除非另有说明,否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问,请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO"],"gpt_icon":0},{"id":"2481400483","title":"Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481400483","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481400483?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:52","pubTimestamp":1731081122,"startTime":"0","endTime":"0","summary":"Fortress Biotech Inc 预计每股亏损59美分 - 财报前瞻Fortress Biotech Inc FBIO.OQ FBIO.O预计将在11月12日公布截至0001年1月1日的业绩报告(估计),季度收入将出现下降。LSEG 分析师对 Fortress Biotech Inc 的平均预期是每股亏损 59 美分。华尔街对 Fortress Biotech Inc 的 12 个月目标价中位数为 13.00 美元,高于其最新收盘价 1.72 美元。11月8日 - 以前季度业绩。除非另有说明,否则所有数据均以美元为单位。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4S3MF1SI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FBIO"],"gpt_icon":0},{"id":"2480030174","title":"美国食品及药物管理局批准 Journey Medical 用于治疗长期皮肤病的药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2480030174","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480030174?lang=zh_cn&edition=full","pubTime":"2024-11-04 20:09","pubTimestamp":1730722152,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透11月4日 - Journey Medical公司周一表示,美国食品和药物管理局已批准该公司生产的 药物用于治疗一种名为酒渣鼻的长期皮肤病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DERM","FBIO","BK4139","BK4007"],"gpt_icon":0},{"id":"2452404939","title":"HC Wainwright & Co.:重申Fortress Biotech(FBIO.US)评级,由买入调整至买入评级, 目标价由24.","url":"https://stock-news.laohu8.com/highlight/detail?id=2452404939","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452404939?lang=zh_cn&edition=full","pubTime":"2024-07-20 01:49","pubTimestamp":1721411359,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["FBIO","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fortressbiotech.com","stockEarnings":[{"period":"1week","weight":-0.0055},{"period":"1month","weight":0.1242},{"period":"3month","weight":0.2837},{"period":"6month","weight":0.0774},{"period":"1year","weight":-0.3418},{"period":"ytd","weight":-0.3987}],"compareEarnings":[{"period":"1week","weight":-0.0049},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.0548},{"period":"6month","weight":0.1005},{"period":"1year","weight":0.2695},{"period":"ytd","weight":0.2651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fortress Biotech, Inc.于2006年6月28日在特拉华州注册成立。它是一家生物制药公司,专注于收购和推进资产,通过产品收入、股权持有、股息和特许权使用费收入流提高股东的长期价值。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.108956},{"month":2,"riseRate":0.666667,"avgChangeRate":0.02724},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.009777},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.022071},{"month":5,"riseRate":0.4,"avgChangeRate":-0.034317},{"month":6,"riseRate":0.3,"avgChangeRate":-0.019274},{"month":7,"riseRate":0.6,"avgChangeRate":-0.008441},{"month":8,"riseRate":0.5,"avgChangeRate":0.024506},{"month":9,"riseRate":0.2,"avgChangeRate":-0.106031},{"month":10,"riseRate":0.3,"avgChangeRate":-0.149116},{"month":11,"riseRate":0.8,"avgChangeRate":0.115939},{"month":12,"riseRate":0.5,"avgChangeRate":0.044203}],"exchange":"NASDAQ","name":"Fortress Biotech Inc.","nameEN":"Fortress Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fortress Biotech Inc.,FBIO,Fortress Biotech Inc.股票,Fortress Biotech Inc.股票老虎,Fortress Biotech Inc.股票老虎国际,Fortress Biotech Inc.行情,Fortress Biotech Inc.股票行情,Fortress Biotech Inc.股价,Fortress Biotech Inc.股市,Fortress Biotech Inc.股票价格,Fortress Biotech Inc.股票交易,Fortress Biotech Inc.股票购买,Fortress Biotech Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fortress Biotech Inc.(FBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fortress Biotech Inc.(FBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}